LAM561 (2-OHOA: 2-hydroxyoleic acid) for GBM: Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032 - Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
January 24, 2024 09:03 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "LAM561 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
SM04690 for Osteoarthritis: Emerging Drug Insight and Market Forecasts to 2032 - Focus on 6 Major Markets
January 24, 2024 08:59 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SM04690 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "SM04690 Emerging Drug...
DCVax-L in Glioblastoma Multiforme Market Forecasts to 2032
January 24, 2024 08:58 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DCVax-L Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The global healthcare...
SVT-15473 Emerging Drug Analysis and Market Forecasts, 2019-2023 and 2023-2029: A New and Innovative Ocular Nano-Emulsion of Super-Potent Steroid Clobetasol Propionate
January 24, 2024 08:14 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SVT-15473 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Global Market Insights...
DEXCYU Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032: A Dexamethasone Intra-ocular Suspension Marketed for Treating Postoperative Inflammation
January 24, 2024 08:13 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DEXCYU Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
K-321 (Ripasudil) for Fuchs Endothelial Corneal Dystrophy (FECD): Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032
January 24, 2024 08:12 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "K-321 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
ONCOS-102: An Oncolytic Adenovirus with an Immune-Stimulating Transgene - Emerging Drug Analysis and Market Forecasts, 2019-2023 and 2023-2032 with Focus on 7 Major Markets
January 24, 2024 08:11 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ONCOS-102 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
PK101 Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032: A NSAID with Increased Effectiveness and Reduced Cardiovascular and Gastrointestinal Side Effects
January 24, 2024 08:10 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "PK101 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. An insightful market forecast...
AMZ001 Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032: A High-strength, Discrete, Odorless, Noninvasive Topical Gel Containing 3.06% Diclofenac Sodium
January 24, 2024 08:09 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "AMZ001 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
SURF-201: 0.2% Betamethasone, A Unique and Potent Corticosteroid - Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032
January 24, 2024 08:08 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SURF-201 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...